Skip to content

Study · Animal study (in vivo) · rat · 1991

2 results

[The predisposition to catatonic reactions, monoamine oxidase and the delta-sleep peptide in rats].

Voĭtenko NN, Kolpakov VG

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova1 Nov 1991

PMID1369574 (opens in a new tab)PepBankPUB-01369574

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In GC rats and in wild catatonic rats, DSIP administration abolished the susceptibility to catatonic reactions.

    In plain wordsIn rats prone to catatonia, DSIP removed the tendency to catatonic reactions.

    Outcome
    DecreaseSusceptibility to catatonic reactions
    Study

    ratn: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Administration of DSIP abolished the susceptibility to catatonic reactions and normalized the MAO B/MAO A ratio both in GC and in wild catatonic rats.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In GC rats and in wild catatonic rats, DSIP administration normalized the raised MAO B/MAO A ratio.

    In plain wordsIn rats prone to catatonia, DSIP brought a raised enzyme ratio (MAO B to MAO A) back to normal.

    Outcome
    DecreaseMAO B/MAO A ratio
    Study

    ratn: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Administration of DSIP abolished the susceptibility to catatonic reactions and normalized the MAO B/MAO A ratio both in GC and in wild catatonic rats.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.